TuHURA Biosciences, Inc.
HURA
$2.42
$0.020.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.58M | 6.52M | 5.55M | 5.29M | 3.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.12M | 24.98M | 21.98M | 19.62M | 17.21M |
| Operating Income | -28.12M | -24.98M | -21.98M | -19.62M | -17.21M |
| Income Before Tax | -30.05M | -29.29M | -27.76M | -23.50M | -21.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.05 | -29.29 | -27.76 | -23.50 | -21.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.05M | -29.29M | -27.76M | -23.50M | -21.68M |
| EBIT | -28.12M | -24.98M | -21.98M | -19.62M | -17.21M |
| EBITDA | -28.05M | -24.91M | -21.90M | -19.52M | -17.09M |
| EPS Basic | -0.64 | -0.66 | -1.06 | -1.28 | -1.52 |
| Normalized Basic EPS | -0.36 | -0.35 | -0.55 | -0.74 | -0.90 |
| EPS Diluted | -0.64 | -0.66 | -1.06 | -1.28 | -1.52 |
| Normalized Diluted EPS | -0.36 | -0.35 | -0.55 | -0.74 | -0.90 |
| Average Basic Shares Outstanding | 191.63M | 176.75M | 138.26M | 105.88M | 74.65M |
| Average Diluted Shares Outstanding | 191.63M | 176.75M | 138.26M | 105.88M | 74.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.03% | -0.02% | -0.02% | -0.01% | -- |